Valuation (22%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 141.02 | 20.53 |
| PEG Ratio (TTM) | -7.52 | 16.29 |
| P/S Ratio (TTM) | 1.24 | 7.08 |
| P/B Ratio (TTM) | 3.54 | 5.99 |
| P/FCF Ratio (TTM) | 24.52 | 17.03 |
| Price to 5YR AVG Earnings Ratio | N/A | 110.54 |
| Price to 5YR AVG FCF Ratio | N/A | 38.63 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.39% | 1.55% |
| ROE (TTM) | 2.62% | 9.07% |
| Net Profit Margin (TTM) | 0.88% | 5.51% |
| ROIC 5YR AVG | N/A | 11.86% |
Growth (23%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -13.21% | -13.96% | N/A |
| Revenue | 0.62% | 13.91% | N/A |
| Net Income | -12.70% | -20.13% | N/A |
| Cash Flow | 112.44% | 155.10% | N/A |
Health (35%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.81 | 2.47 |
| Quick Ratio (TTM) | 1.81 | 2.29 |
| D/E Ratio (TTM) | 0.01 | 0.72 |
| Interest Coverage (TTM) | 0.00 | 6.71 |
| Piotroski F-Score | 5 | 5 |
| Altman Z-Score | N/A | 7.53 |
| LTL to 5YR AVG FCF | N/A | 2.07 |
| Shares Outstanding Growth 5YR AVG | N/A | 4.76% |